Jenburkt Pharmaceuticals

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue35.5133.0028.2931.1335.85
Expenses25.6926.5024.1824.3927.78
EBITDA9.826.504.116.748.07
EBIT9.376.033.576.207.53
Profit Before Tax10.907.685.277.799.24
Net Profit7.976.233.455.956.87
Financial Ratios
Operating Profit Margin27.65%19.70%14.53%21.65%22.51%
Net Profit Margin22.44%18.88%12.20%19.11%19.16%
Earning Per Share (Diluted)17.3713.577.5112.9714.96
Dividends Per ShareNANA12.00NANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.6.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI